๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Role of etoposide-based chemotherapy in the treatment of patients with refractory or relapsing germ cell tumors

โœ Scribed by George J. Bosl; Alan Yagoda; Robert B. Golbey; Willet Whitmore Jr.; Harry Herr; Pramod Sogani; Michael Morse; Nicholas Vogelzang; G. Macdonald

Book ID
115680575
Publisher
Elsevier Science
Year
1985
Tongue
English
Weight
635 KB
Volume
78
Category
Article
ISSN
1555-7162

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

The role of ifosfamide plus cisplatin-ba
The role of ifosfamide plus cisplatin-based chemotherapy as salvage therapy for patients with refractory germ cell tumors
โœ Robert J. Motzer; Karen Cooper; Nancy L. Geller; Dean F. Bajorin; Ethan Dmitrovs ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 537 KB

A prospective study of four cycles of etoposide with ifosfamide and cisplatin (VIP) chemotherapy was conducted in 42 germ cell tumor (GCT) patients who were refractory to cisplatin with etoposide/vinblastine-based therapy. Forty patients were evaluable for response. Ten patients (25%) had a complete